Global Custom Market Research Reports Provider Company


Evgen Pharma Plc (EVG) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United Kingdom

Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Limited is a drug discovery company that develops medicines with concentration on cancer and neurological diseases. The company carries out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. It uses sulforadex technology that synthesizes and concurrently stabilizes the naturally occurring compound such as sulforaphane. Evgen Pharmas SFX-01 is a patented composition of the synthetic sulforaphane and alpha-cyclodextrin and has completed phase I clinical trials. The company also undertakes clinical plans in oncology in patients with ER+ metastatic breast cancer. Evgen Pharma is headquartered in Liverpool, the UK.

Evgen Pharma Plc Key Recent Developments

Jun 13,2017: Evgen Pharma Announces Final Results for the year ended 31 March 2017
Apr 03,2017: Evgen Pharma Announces Directorate Change
Jan 17,2017: Evgen Pharma: Appointment of CFO and Head of Clinical Operations
Dec 05,2016: Evgen Pharma: Interim results for the six months ended 30 September 2016
May 31,2016: Evgen Pharma Announces Final Results for the year ended 31 March 2016

This comprehensive SWOT profile of Evgen Pharma Plc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Evgen Pharma Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents

Section 1 - About the Company

Evgen Pharma Plc - Key Information

Evgen Pharma Plc - Overview

Evgen Pharma Plc - Key Employees

Evgen Pharma Plc - Key Employee Biographies

Evgen Pharma Plc - Key Operational Heads

Evgen Pharma Plc - Major Products and Services

Evgen Pharma Plc - History

Evgen Pharma Plc - Company Statement

Evgen Pharma Plc - Locations And Subsidiaries

Evgen Pharma Plc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

Evgen Pharma Plc - Business Description

Evgen Pharma Plc - Corporate Strategy

Evgen Pharma Plc - SWOT Analysis

SWOT Analysis - Overview

Evgen Pharma Plc - Strengths

Evgen Pharma Plc - Weaknesses

Evgen Pharma Plc - Opportunities

Evgen Pharma Plc - Threats

Evgen Pharma Plc - Key Competitors

Section 3 - Company Financial Performance Charts

Evgen Pharma Plc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Appendix



Ratio Definitions

About GlobalData

Contact Us


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

Evgen Pharma Plc, Key Information

Evgen Pharma Plc, Key Ratios

Evgen Pharma Plc, Share Data

Evgen Pharma Plc, Major Products and Services

Evgen Pharma Plc, History

Evgen Pharma Plc, Key Employees

Evgen Pharma Plc, Key Employee Biographies

Evgen Pharma Plc, Key Operational Heads

Evgen Pharma Plc, Other Locations

Evgen Pharma Plc, Subsidiaries

Evgen Pharma Plc, Key Manufacturing facilities

Evgen Pharma Plc, Key Competitors

Evgen Pharma Plc, SWOT Analysis

Evgen Pharma Plc, Ratios based on current share price

Evgen Pharma Plc, Annual Ratios

Evgen Pharma Plc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures

Evgen Pharma Plc, Performance Chart

Evgen Pharma Plc, Ratio Charts

Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Limited is a drug discovery company that develops medicines with concentration on cancer and neurological diseases. The company carries out preclinical work

View Report

Devgen NV (DEVG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile market research report at USD 250 and market update available at JSB Market Research.

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports